GO:0038179 neurotrophin signaling pathway: Neuronal Survival and Plasticity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038179 (neurotrophin signaling pathway) describes the molecular cascade triggered when secreted neurotrophins bind to surface receptors, leading to regulation of transcription and other cellular processes.
• The pathway is essential for neuronal survival, development, and function, and its dysregulation is linked to neurodegeneration, cancer, and mood disorders.
• Key receptors include TrkA, TrkB, TrkC, and p75NTR, which activate distinct downstream signaling branches such as Ras/MAPK, PI3K/Akt, and PLCγ.
• Neurotrophin signaling can be studied using knockout, point-mutation, knock-in, and overexpression models, as well as CRISPR library screening and bioinformatics.
• The pathway is regulated by feedback mechanisms, including glucocorticoid receptor signaling and m6A epitranscriptomic modifications.
• Understanding GO:0038179 provides insights into neuronal plasticity, cancer stem cell biology, and potential therapeutic targets.
Description
The neurotrophin signaling pathway (GO:0038179) is a fundamental biological process that governs neuronal survival, differentiation, and synaptic plasticity. It is initiated by the binding of neurotrophins, a family of secreted growth factors, to specific receptors on the surface of target cells, culminating in the regulation of downstream cellular responses including transcription. This pathway is critical for the development and maintenance of the nervous system, and its perturbation is implicated in a wide range of pathologies from neurodegenerative diseases to cancer. Researchers studying neurotrophin signaling seek to understand how these molecular events orchestrate complex physiological outcomes and how they can be targeted therapeutically. The pathway's complexity arises from the interplay between different neurotrophins (e.g., NGF, BDNF, NT-3, NT-4) and their receptors (TrkA, TrkB, TrkC, and p75NTR), which activate overlapping yet distinct signaling cascades. This article provides a comprehensive overview of the neurotrophin signaling pathway, its molecular components, its role in health and disease, and the experimental approaches used to study it, with a focus on CRISPR-based models and services offered by EDITGENE.
neurotrophin signaling pathway At A Glance
| GO ID | GO:0038179 |
|---|---|
| GO term | neurotrophin signaling pathway |
| Ontology | biological_process |
| Synonym | neurotrophin receptor signaling pathway |
| Major function | Induces neuronal survival, development, and function through receptor-mediated signaling |
| Key receptors | TrkA (NTRK1), TrkB (NTRK2), TrkC (NTRK3), p75NTR (NGFR) |
| Key ligands | NGF, BDNF, NT-3, NT-4 |
| Downstream pathways | Ras/MAPK, PI3K/Akt, PLCγ |
| Disease relevance | Neurodegeneration, cancer, depression, tau pathology |
What Is GO:0038179?
According to the Gene Ontology, GO:0038179 (neurotrophin signaling pathway) is defined as the series of molecular signals initiated by neurotrophin binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Neurotrophins are a family of secreted growth factors that induce the survival, development, and function of neurons. In essence, it is the entire communication system that translates an extracellular neurotrophin cue into a functional change within the cell, often through receptor activation and intracellular signaling cascades.
Why Is neurotrophin signaling pathway Important in Cell Biology?
The neurotrophin signaling pathway is indispensable for the proper development and maintenance of the nervous system, and its dysfunction is a common thread in numerous human diseases. It controls neuronal survival and death decisions, axon guidance, synaptic plasticity, and even cancer stem cell behavior. Because of its broad impact, understanding this pathway is crucial for developing therapies for neurodegenerative conditions, psychiatric disorders, and cancers.
• Regulates neuronal survival and apoptosis during development and in adulthood.
• Controls synaptic plasticity and memory formation, with implications for learning and mood disorders.
• Implicated in neurodegenerative diseases such as Alzheimer's and tauopathies.
• Plays a role in cancer stem cell maintenance and tumor progression.
• Modulated by glucocorticoid receptor signaling, linking stress to neuronal pathology.
• Subject to epitranscriptomic regulation via m6A modification, affecting depression-like behaviors.
• Provides targets for therapeutic intervention in neuropsychiatric and oncological disorders.
• Serves as a paradigm for understanding growth factor signaling mechanisms.
• Essential for the development of sensory and sympathetic neurons.
• Its dysregulation can lead to chemotherapy-induced peripheral neuropathy and other conditions.
What Happens During neurotrophin signaling pathway?
Neurotrophin Binding and Receptor Activation
In simple terms: Neurotrophins act like keys that fit into specific locks (receptors) on the cell surface, turning on the signaling process.
The pathway begins when a secreted neurotrophin (e.g., NGF, BDNF, NT-3, NT-4) binds to its cognate receptor on the target cell surface. The primary receptors are the Trk family of receptor tyrosine kinases (TrkA, TrkB, TrkC) and the p75 neurotrophin receptor (p75NTR). Binding induces receptor dimerization and autophosphorylation of tyrosine residues in the intracellular domain, creating docking sites for adaptor proteins. This activation is the critical first step that initiates downstream signaling cascades.
Intracellular Signaling Cascades
In simple terms: Once the receptor is activated, it triggers a relay race of proteins inside the cell that carry the signal to different destinations.
Activated Trk receptors recruit adaptor proteins such as Shc, Grb2, and PLCγ, leading to the activation of three major signaling pathways: the Ras/MAPK pathway (promoting differentiation and growth), the PI3K/Akt pathway (promoting survival), and the PLCγ pathway (regulating calcium signaling and synaptic plasticity). p75NTR can activate distinct pathways, including NF-κB and JNK, often influencing cell death or survival depending on context. These cascades involve phosphorylation events and second messengers that amplify and diversify the signal.
Regulation of Downstream Cellular Processes
In simple terms: The signal ultimately reaches the cell's command center, changing gene expression and other functions to produce a response like survival or growth.
The signaling cascades converge on the nucleus and other organelles to regulate transcription factors such as CREB, which control genes involved in neuronal survival, differentiation, and plasticity. The pathway also modulates local protein synthesis, cytoskeletal dynamics, and membrane trafficking, contributing to processes like axon growth and synaptic strengthening. The ultimate outcome depends on the cell type, developmental stage, and the specific neurotrophin-receptor pair engaged.
Feedback and Crosstalk
In simple terms: The pathway has built-in brakes and intersections with other signals to keep responses balanced.
Neurotrophin signaling is tightly regulated by negative feedback mechanisms, including receptor internalization and degradation, and by phosphatases that dephosphorylate key components. There is also extensive crosstalk with other signaling pathways, such as the glucocorticoid receptor pathway, which can modulate neurotrophin signaling and influence neuronal vulnerability. Additionally, epitranscriptomic modifications like m6A can affect the expression of genes in the pathway, as shown in depression models.
Key Genes Involved in GO:0038179 neurotrophin signaling pathway
The following genes encode the core components of the neurotrophin signaling pathway, including ligands, receptors, and downstream effectors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGF | Neurotrophin ligand; binds TrkA and p75NTR | Studied for pain, neurodegeneration, and neuroprotection |
| BDNF | Neurotrophin ligand; binds TrkB and p75NTR | Linked to depression, memory, and synaptic plasticity |
| NTF3 | Neurotrophin ligand (NT-3); binds TrkC and p75NTR | Involved in proprioceptive neuron development |
| NTF4 | Neurotrophin ligand (NT-4); binds TrkB and p75NTR | Studied in sensory neuron survival |
| NTRK1 | TrkA receptor tyrosine kinase | Mutations cause congenital insensitivity to pain; cancer target |
| NTRK2 | TrkB receptor tyrosine kinase | Implicated in mood disorders and obesity |
| NTRK3 | TrkC receptor tyrosine kinase | Roles in development and cancer |
| NGFR | p75 neurotrophin receptor | Regulates survival/death decisions; cancer stem cells |
| RAS | Small GTPase; activates MAPK pathway | Proto-oncogene; downstream of Trk |
| MAPK1 | ERK2; effector of Ras/MAPK pathway | Controls proliferation and differentiation |
| PIK3CA | PI3K catalytic subunit; activates Akt | Promotes cell survival; mutated in cancers |
| AKT1 | Serine/threonine kinase; survival signaling | Key node in neurotrophin-mediated survival |
| PLCG1 | Phospholipase C gamma 1 | Mediates calcium signaling and plasticity |
| SHC1 | Adaptor protein; links Trk to Ras/MAPK | Essential for neurotrophin signaling |
| GRB2 | Adaptor protein; recruits SOS to Ras | Central in RTK signaling |
| CREB1 | Transcription factor; regulates survival genes | Downstream target of neurotrophin signaling |
| NFKB1 | Transcription factor; mediates p75NTR signaling | Influences survival and inflammation |
| JUN | Transcription factor; activated by JNK | Mediates stress responses and apoptosis |
How Is neurotrophin signaling pathway Regulated?
The neurotrophin signaling pathway is subject to multiple layers of regulation. At the receptor level, activation is controlled by ligand availability, receptor trafficking, and negative feedback via phosphatases such as SHP-1. Intracellularly, the pathway intersects with the glucocorticoid receptor signaling, where deletion of neurotrophin signaling through this pathway causes tau neuropathology. Additionally, epitranscriptomic regulation by m6A modification can influence the expression of neurotrophin signaling components, as demonstrated in depression-like behaviors. These regulatory mechanisms ensure appropriate signal duration and intensity, and their disruption contributes to disease.
neurotrophin signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NTRK2 | Depression, mood disorders | Knockout mouse, point mutation (e.g., BDNF binding site) |
| NGFR | Cancer stem cell maintenance | Overexpression in cancer cell lines, knockout in stem cells |
| NTRK1 | Congenital insensitivity to pain | Knock-in of patient mutations in iPSCs |
| BDNF | Alzheimer's disease, depression | Knock-in of Val66Met polymorphism |
| GR | Tau neuropathology | Conditional knockout of glucocorticoid receptor in neurons |
Neurodegenerative Diseases
Impaired neurotrophin signaling is a hallmark of several neurodegenerative conditions. For instance, deletion of neurotrophin signaling through the glucocorticoid receptor pathway leads to tau neuropathology, a key feature of Alzheimer's disease and related tauopathies. Reduced BDNF-TrkB signaling has been associated with cognitive decline and mood disorders. Targeting this pathway may offer therapeutic strategies for neuroprotection.
Cancer
Neurotrophin signaling plays a dual role in cancer. It can promote tumor cell survival and proliferation, and is implicated in cancer stem cell maintenance. Trk receptor fusions and mutations are oncogenic drivers in various cancers, making them attractive targets for precision medicine. p75NTR can also influence tumor progression and metastasis.
Psychiatric Disorders
Dysregulation of neurotrophin signaling, particularly BDNF, is linked to depression and anxiety. Hypericin, a natural compound, ameliorates depression-like behaviors via the neurotrophin signaling pathway by mediating m6A epitranscriptome modification. This highlights the pathway's role in mood regulation and its potential as a therapeutic target.
From neurotrophin signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TrkB affect neuronal survival? | TrkB knockout mouse or CRISPR KO in primary neurons |
| How does a point mutation in NTRK1 alter signaling? | Knock-in of point mutation in cell lines or iPSCs |
| Can overexpression of BDNF rescue depression-like behavior? | BDNF overexpression viral vector in mouse brain |
| What is the role of p75NTR in cancer stem cells? | CRISPR KO of NGFR in cancer stem cell lines |
| How does m6A modification regulate neurotrophin signaling? | Knockout of m6A writers/erasers followed by RNA-seq |
| Can a tagged TrkB be used to track receptor trafficking? | Knock-in of fluorescent tag at NTRK2 locus |
How to Study the neurotrophin signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify transcriptional targets of neurotrophin signaling |
| m6A-seq | RNA methylation sites | Study epitranscriptomic regulation of pathway genes |
| Phosphoproteomics | Phosphorylation events | Map signaling cascades downstream of Trk receptors |
| Live-cell imaging | Receptor dynamics and localization | Track TrkB trafficking and signaling in neurons |
| CRISPR knockout screen | Gene essentiality and modifiers | Discover regulators of neurotrophin-dependent survival |
| CRISPR activation screen | Gene overexpression effects | Identify enhancers of neurotrophin signaling |
| Proximity ligation assay | Protein-protein interactions | Detect receptor-adaptor complexes |
| Patch-clamp electrophysiology | Neuronal excitability and synaptic function | Assess functional outcomes of neurotrophin signaling |
Transcriptomic and Epitranscriptomic Profiling
RNA-seq and m6A-seq can reveal changes in gene expression and RNA modifications in neurotrophin signaling components. For example, hypericin treatment alters the m6A epitranscriptome in depression models, affecting neurotrophin signaling. These methods help identify downstream targets and regulatory networks.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can quantify protein expression and phosphorylation events following neurotrophin stimulation. This is crucial for mapping the signaling cascades activated by Trk receptors and identifying novel effectors.
Imaging and Live-Cell Tracking
Fluorescence microscopy and live-cell imaging of tagged receptors (e.g., GFP-TrkB) allow visualization of receptor trafficking, dimerization, and downstream signaling dynamics in real time. This provides spatial and temporal insights into pathway activation.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate neurotrophin signaling, such as those affecting neuronal survival or cancer stem cell maintenance. These screens are powerful for discovering new pathway components and therapeutic targets.
How CRISPR Can Be Used to Study GO:0038179 neurotrophin signaling pathway
Knockout
CRISPR knockout of key neurotrophin signaling genes (e.g., NTRK2, NGFR) in cell lines or primary neurons can elucidate their roles in survival, differentiation, and disease. For example, knocking out NGFR in cancer stem cells can test its role in self-renewal.
Point Mutation
Introducing disease-associated point mutations (e.g., NTRK1 mutations causing congenital insensitivity to pain) via CRISPR base editing or HDR allows precise modeling of signaling alterations and drug responses.
Knock-in
Knock-in of fluorescent tags (e.g., GFP at the NTRK2 locus) enables real-time tracking of receptor expression and localization. Knock-in of patient-specific mutations in iPSCs provides a platform for personalized disease modeling.
Overexpression
CRISPR activation (CRISPRa) or viral overexpression of neurotrophins (e.g., BDNF) can enhance pathway activity, useful for studying neuroprotection and rescue experiments in disease models.
How EDITGENE Supports neurotrophin signaling pathway Research
Researchers studying neurotrophin signaling pathway-related genes often need to determine whether a candidate gene is causally involved in neuronal survival, cancer stemness, or mood regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to create precise cellular and animal models, enabling rigorous functional validation of genes within GO:0038179.
Contact EDITGENE today to design your custom CRISPR model for neurotrophin signaling pathway research.
Frequently Asked Questions About neurotrophin signaling pathway
What is the neurotrophin signaling pathway?
The neurotrophin signaling pathway (GO:0038179) is the series of molecular signals initiated by neurotrophin binding to its receptor on the cell surface, leading to regulation of downstream cellular processes such as transcription. It is essential for neuronal survival, development, and function.
What genes are involved in neurotrophin signaling pathway?
Key genes include neurotrophins (NGF, BDNF, NTF3, NTF4), receptors (NTRK1, NTRK2, NTRK3, NGFR), and downstream effectors (RAS, MAPK1, PIK3CA, AKT1, PLCG1, SHC1, GRB2, CREB1).
What diseases are associated with neurotrophin signaling pathway?
Dysregulation is linked to neurodegenerative diseases (e.g., Alzheimer's, tauopathies), cancer, and psychiatric disorders like depression.
How is neurotrophin signaling pathway regulated?
It is regulated by receptor trafficking, phosphatases, crosstalk with glucocorticoid receptor signaling, and epitranscriptomic modifications such as m6A.
What are the main receptors in neurotrophin signaling?
The main receptors are TrkA (NTRK1), TrkB (NTRK2), TrkC (NTRK3), and p75NTR (NGFR).
How can I study neurotrophin signaling pathway using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect gene function. EDITGENE offers these services along with library screening and bioinformatics.
What is the role of BDNF in neurotrophin signaling?
BDNF is a neurotrophin that binds TrkB and p75NTR, activating pathways that promote neuronal survival, synaptic plasticity, and mood regulation.
What is p75NTR and how does it signal?
p75NTR (NGFR) is a neurotrophin receptor that can activate NF-κB and JNK pathways, often influencing cell death or survival decisions.
Can neurotrophin signaling be targeted for cancer therapy?
Yes, Trk receptor fusions and mutations are oncogenic, and p75NTR is implicated in cancer stem cells, making them potential therapeutic targets.
What methods are used to study neurotrophin signaling pathway?
Common methods include RNA-seq, m6A-seq, phosphoproteomics, live-cell imaging, CRISPR screens, and electrophysiology.
Conclusion
The neurotrophin signaling pathway (GO:0038179) is a central regulator of neuronal life and death, with far-reaching implications for development, plasticity, and disease. Its complexity and crosstalk with other pathways make it a rich area for research, and CRISPR-based models are invaluable for dissecting gene function. EDITGENE's comprehensive services empower researchers to create precise models and accelerate discoveries in this critical pathway.
References
- 1. Huang EJ et al.. 2003. Trk receptors: roles in neuronal signal transduction.. Annu Rev Biochem 72:609-42 PMID: 12676795
- 2. Huang EJ et al.. 2001. Neurotrophins: roles in neuronal development and function.. Annu Rev Neurosci 24:677-736 PMID: 11520916
- 3. Dechant G et al.. 2002. Neurotrophins.. Adv Exp Med Biol 513:303-34 PMID: 12575826
- 4. Lei C et al.. 2023. Hypericin Ameliorates Depression-like Behaviors via Neurotrophin Signaling Pathway Mediating m6A Epitranscriptome Modification.. Molecules 28(9) PMID: 37175269
- 5. Arévalo JC et al.. 2006. Neurotrophin signaling: many exciting surprises!. Cell Mol Life Sci 63(13):1523-37 PMID: 16699811
- 6. Friedman WJ et al.. 1999. Neurotrophin signaling via Trks and p75.. Exp Cell Res 253(1):131-42 PMID: 10579918
- 7. Chopin V et al.. 2016. Neurotrophin signaling in cancer stem cells.. Cell Mol Life Sci 73(9):1859-70 PMID: 26883804
- 8. Arango-Lievano M et al.. 2016. Deletion of Neurotrophin Signaling through the Glucocorticoid Receptor Pathway Causes Tau Neuropathology.. Sci Rep 6:37231 PMID: 27849045
